Biopticon Corporation news
Visit us at our booth #407. We are announcing the launch of our next generation 3D scanner for subcutaneous tumors on mice and rats. We simply named it TumorImager 2TM. We will demonstrate both hands-free and hand-held versions during the convention from June 15th through 17th.
This venue was postponed until further notice.
We are going to present our TMS for the 10th time during the 2020 AACR in San Diego (April 26th- April 29th).
Visit our booth #231 at 18th Annual WPC in Boston, June 17-20, 2019 to view our company’s latest products and advancements.
We are going to present our TMS for the 9th time during the 2019 AACR in Atlanta (March 29th– April 3rd). Please visit
Our second European presence is at World Preclinical Congress meeting in Lisbon, Portugal. Visit our booth #14 between November 27-30.
This is our 8th year at the show. We would be happy to show you our new imager, TumorImager-2TM. Please visit us at our booth #1921.
This year, we are going to present TMS for the first time in Europe. Visit our booth #117 at ESMO (European Society for Medical Oncology) 2018 in Munich Germany, in October 19-23.
Visit us at our booth #942
Washington DC, April 1-5, 2017
Biopticon will be in Washington DC for the annual 2017 AACR convention. Visit us at our booth Biopticon Corporation Booth.
Biopticon Corporation Announces the release of the new version of their innovative TumorManagerTM Program for managing pre-clinical oncology study data
Innovative instrument and software create revolutionary system to improve data, work-flow and results from in vivo cancer models
Princeton, NJ
Biopticon today released the latest version of their
Biopticon Corporation reaches milestone in market adoption of their innovative Tumor Management System for preclinical oncology studies.
Innovative instrument and software create revolutionary system to improve data, work-flow and results from in vivo cancer models
Princeton, NJ Biopticon today announced that it had met its first milestone for customer adoption of the revolutionary
